Clinical Trials Directory

Trials / Completed

CompletedNCT03813459

Subsyndromal Delirium in Intensive Care Unit

Subsyndromal Delirium in Intensive Care Unit, a Multicenter Study

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Centro Hospitalar Lisboa Ocidental · Other Government
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Subsyndromal delirium (SSD) is a condition characterized by a less severe cognitive impairment in comparison to delirium. To date there is no published consensus on SSD definitions and has been commonly reported as an intermediate stage between delirium and normal mental states. SSD encompasses some of the delirium symptoms, and has been diagnosed with Intensive Care Delirium Screening Checklist scale (ICDSC) and Confusion Assessment Method-ICU (CAM-ICU). The objective of this study is to identify subsyndromal delirium prevalence, the association between SSD and clinical outcomes and understanding the relationship between SSD and conversion to delirium. The relevance of this study is understanding of subsyndromal delirium in ICU, namely the importance of early presentations of acute brain dysfunction in the patients outcome.

Detailed description

SubSynD is a prospective, observational, multicenter clinical study, involving 400 patients in Intensive Care Units, to assess subsyndromal delirium. A systematic screening for delirium and subsyndromal delirium (SSD) is done with Intensive Care Delirium Screening Checklist (ICDSC) and Confusion Assessment Method-ICU (CAM-ICU). Scales are applied once per day until ICU discharge or for up to 14 days of being in ICU. The investigators access three different groups of patients: non-delirium, delirium and subsyndromal delirium. It is intended that either ICDSC or CAM-ICU, paired with a Richmond Agitation and Sedation Scale (RASS) be administered once per day (i.e. with first assessment in the morning). All patients with abnormal CAM-ICU or ICDSC features, beside the underlying cause of delirium and SSD are included. In addition, data regarding baseline demographic and clinical characteristics will be collected as well as data regarding the procedure performed (see Case Report Form (CRF)).

Conditions

Timeline

Start date
2018-08-01
Primary completion
2019-09-01
Completion
2020-03-31
First posted
2019-01-23
Last updated
2021-12-14

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT03813459. Inclusion in this directory is not an endorsement.